|
141
|
|
|
Potassium calcium-activated channel subfamily M regulatory beta subunit 1 |
BKbeta1, K(VCA)beta, SLO-BETA, hbeta1, hslo-beta, k(VCA)beta-1, slo-beta-1 |
|
|
142
|
|
|
Potassium calcium-activated channel subfamily N member 1 |
KCa2.1, SK1, SKCA1, hSK1 |
|
|
143
|
|
|
Potassium calcium-activated channel subfamily N member 2 |
DYT34, KCa2.2, NEDMAB, SK2, SKCA2, SKCa 2, hSK2 |
Alzheimer disease, Cardiac arrhythmias, Atrial fibrillation, Autism, Bipolar disorder, Hepatocellular carcinoma, Cardiac arrest, Cardiac arrhythmia, Cardioembolic stroke, Cardiovascular disease, Cerebellar ataxia, Congenital heart disease, Coronary aneurysm, Dyskinesia, Dystonia, Edema, Global developmental delay, Congenital heart septal defect, Hepatitis b, Intellectual developmental disorder, Juvenile idiopathic arthritis, Major depressive disorder, Intellectual disability, Neurodevelopmental disorder, Neurodevelopmental disorders, Obesity, Psoriasis, Schizophrenia, Stroke, Diabetes mellitus, type 1, Diabetes mellitus, type 2View all (16 more) |
|
144
|
|
|
Potassium calcium-activated channel subfamily N member 3 |
KCa2.3, SK3, SKCA3, ZLS3, hSK3 |
Alzheimer disease, Atrial fibrillation, Atrial flutter, Bipolar disorder, Cardiac arrhythmia, Cardiac embolism, Cardioembolic stroke, Central nervous system cancer, Cholecystolithiasis, Paranoid schizophrenia, Dyslexia, Esophageal atresia, Glaucoma, Glioblastoma, Glioma, Obesity, Schizophrenia, Parkinson disease, Proliferative diabetic retinopathy, Prostate cancer, Squamous cell carcinoma, Zimmermann-laband syndrome View all (7 more) |
|
145
|
|
|
Potassium calcium-activated channel subfamily N member 4 |
DHS2, IK, IK1, IKCA1, KCA4, KCa3.1, SK4, SKCa4, hIK1, hIKCa1, hKCa4, hSK4 |
|
|
146
|
|
|
Potassium voltage-gated channel subfamily Q member 1 |
ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, KVLQT1, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS |
Cardiac arrhythmias, Atrial fibrillation, Beckwith-wiedemann syndrome, Biliary tract cancer, Breast cancer, Brugada syndrome, Cancer, Cardiac arrhythmia, Cardiovascular disease, Cervical cancer, Kidney disease, Clear cell renal cell carcinoma , Color vision deficiency, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Diabetes mellitus type 2, Diabetic eye disease, Diabetic neuropathy, Diabetic polyneuropathy, Diabetic retinopathy, Endometrial cancer, Esophageal cancer, Estrogen-receptor negative breast cancer, Long qt syndrome, Gastric cancer, Gestational diabetes, Gout, Hearing impairment, Hepatocellular carcinoma, Hereditary atrial fibrillation, Hypertrophic cardiomyopathy, Hyperuricemia, Intestinal neoplasm, Jervell and lange-nielsen syndrome, Kidney cancer, Long qt syndrome digenic, Lung cancer, Metabolic syndrome, Non-hodgkins lymphoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Paroxysmal atrial fibrillation, Prostate cancer, Short qt syndrome, Squamous cell carcinoma, Stroke, Hypertension, Diabetes mellitus, type 1, Diabetes mellitus, type 2, Type 2 diabetes nephropathy, Polymorphic ventricular tachycardia, Wolff-parkinson-white syndromeView all (39 more) |
|
147
|
|
|
Potassium voltage-gated channel subfamily Q member 2 |
BFNC, DEE7, EBN, EBN1, ENB1, HNSPC, KCNA11, KV7.2 |
Alzheimer disease, Autism, Nonsyndromic intellectual disability, Bipolar disorder, Brain disease, Neurodevelopmental disorder, Developmental and epileptic encephalopathy, Developmental disability, Epilepsy, Epilepsy of infancy with migrating focal seizures, Benign neonatal epilepsy, Global developmental delay, Intellectual developmental disorder, Major depressive disorder, Malignant migrating partial seizures of infancy, Nervous system disease, Neurodevelopmental disorders, Non-specific syndromic intellectual disability, Schizophrenia, Seizures, Tuberculosis, West syndromeView all (7 more) |
|
148
|
|
|
Potassium voltage-gated channel subfamily Q member 3 |
BFNC2, EBN2, KV7.3 |
Autism, Bipolar disorder, Neurodevelopmental disorder, Developmental and epileptic encephalopathy, Differentiated thyroid carcinoma, Benign neonatal epilepsy, Rolandic epilepsy, Insomnia, Intellectual developmental disorder, Myoclonic epilepsy, Major depressive disorder, Neurodevelopmental disorders, Nonalcoholic fatty liver disease, Non-specific syndromic intellectual disability, Schizophrenia, Seizures, Intellectual disability, Diabetes mellitus, type 2View all (3 more) |
|
149
|
|
|
Potassium voltage-gated channel modifier subfamily S member 3 |
KV9.3 |
Amyotrophic lateral sclerosis, Autism, Breast cancer, Obstructive pulmonary disease, Colorectal cancer, Conotruncal cardiac defect, Coronary artery disease, Gout, Ovarian epithelial cancer, Metastatic colorectal cancer, Multinodular goiter, Oligodendroglioma, Ovarian cancer, Parkinson disease, Peptic ulcer disease, Schizophrenia, Scoliosis, Diabetes mellitus, type 2View all (3 more) |
|
150
|
|
|
Kinase insert domain receptor |
CD309, FLK1, VEGFR, VEGFR2 |
Breast neoplasm, Capillary infantile hemangioma, Cerebral hemorrhage, Colorectal neoplasm, Congenital cartilage disorder, Diabetic neuropathy, Digestive system disease, Endocrine neoplasm, Endometriosis, Temporal lobe epilepsy, Esophageal neoplasm, Age-related macular degeneration, Eye neoplasms, Hemangiosarcoma, Hypertension, Liver neoplasm, Lung neoplasms, Macular degeneration, Major depressive disorder, Myocardial infarction, Myocardial ischemia, Osteochondrodysplasias, Otosclerosis, Premature ovarian failure, Ovarian neoplasm, Pancreatic neoplasm, Pulmonary arterial hypertension, Schizophrenia, Myopia, Depression, Uremia, Venous thrombosisView all (17 more) |